Effect of dexmedetomidine against lipid accumulation in hepatocytes and related mechanism

Tao Linfen; Xu Jianping; Lin Donghong; Li Xi

doi:10.13406/j.cnki.cyxb.003363

您当前的位置：

首页 >

文章列表页 >

Effect of dexmedetomidine against lipid accumulation in hepatocytes and related mechanism

Basic research | 更新时间：2025-10-22

- Effect of dexmedetomidine against lipid accumulation in hepatocytes and related mechanism
- Journal of Chongqing Medical University Vol. 48, Issue 10, Pages: 1215-1220(2023)
- 作者机构：
  
  1.福建医科大学医学技术与工程学院医学检验系，福建 350004
  2.重庆医科大学生命科学研究院，重庆 400032
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003363
  CLC： R575
- Received：05 June 2023，
  
  Revised：2023-06-26，
  
  Accepted：11 September 2023，
  
  Published：28 October 2023
- 稿件说明：
移动端阅览
陶林芬,徐建萍,林东红,等.右美托咪定抑制肝细胞脂质累积的作用及机制研究[J].重庆医科大学学报,2023,48(10):1215-1220.

Tao Linfen,Xu Jianping,Lin Donghong,et al.Effect of dexmedetomidine against lipid accumulation in hepatocytes and related mechanism[J].Journal of Chongqing Medical University,2023,48(10):1215-1220.
陶林芬,徐建萍,林东红,等.右美托咪定抑制肝细胞脂质累积的作用及机制研究[J].重庆医科大学学报,2023,48(10):1215-1220. DOI： 10.13406/j.cnki.cyxb.003363.

Tao Linfen,Xu Jianping,Lin Donghong,et al.Effect of dexmedetomidine against lipid accumulation in hepatocytes and related mechanism[J].Journal of Chongqing Medical University,2023,48(10):1215-1220. DOI： 10.13406/j.cnki.cyxb.003363.

摘要

目的

探讨右美托咪定（dexmedetomidine，DEX）对肝细胞脂质代谢过程的调控作用及可能机制。

方法

分离小鼠原代肝脏细胞，用游离脂肪酸处理24 h构建肝细胞脂质累积模型，分别用浓度200 ng/mL，500 ng/mL和1 000 ng/mL的DEX药物处理原代肝脏细胞24 h。收集细胞进行油红O染色观察细胞中脂质累积情况；通过实时荧光定量PCR和免疫印迹技术检测细胞脂质代谢关键基因的表达情况；通过实时荧光定量PCR检测DEX处理不同作用时间点α

-肾上腺素受体的表达变化情况；进一步通过免疫印迹技术探究DEX对相关信号通路蛋白表达的影响。

结果

不同浓度DEX药物处理原代肝脏细胞后，细胞中脂质累积明显减少，且呈剂量依赖性。与脂肪酸和甘油三酯合成的关键基因如脂肪酸合成酶、硬脂酰辅酶A去饱和酶1及过氧化物酶体增殖物激活受体γ的表达显著被抑制（

0.05）；α

-肾上腺素受体的表达先升高后被抑制；DEX药物可显著降低原代肝脏细胞P65和P38的磷酸化水平（

0.05）。

结论

DEX可减轻肝脏细胞脂质累积，其机制可能与细胞α

-肾上腺素受体和MAPK/NF-κB信号通路被抑制有关。

Abstract

Objective

To investigate the regulatory effect of dexmedetomidine（DEX） on lipid metabolism in hepatocytes and the underlying mechanism.

Methods

Primary mouse hepatocytes were isolated and then treated with free fatty acids for 24 hours to establish a hepatocyte lipid accumulation model. Primary hepatocytes were treated with DEX separately at concentrations of 200 ng/mL，500 ng/mL，and 1 000 ng/mL for 24 hours，and then were collected for Oil Red O staining to observe the level of lipid accumulation. The expression levels of key lipid metabolism genes in hepatocytes were determined by real-time quantitative PCR and Western blot. The expression of α

-adrenoceptors at different time points of DEX treatment was measured by real-time quantitative PCR. The protein expression of associated signaling pathways was determined by Western blot.

Results

The level of lipid accumulation in primary hepatocytes was significantly reduced after treatment with DEX in a dose-dependent manner. The expression levels of key genes related to fatty acid and triglyceride synthesis（including fatty acid synthase，stearoyl-coenzyme A desaturase 1，and peroxisome proliferator-activated receptor γ） were significantly inhibited（

0.05）. The expression of α

-adrenoceptors was firstly increased and then inhibited. In addition，DEX significantly decreased the phosphorylation levels of P65 and P38 in primary hepatocytes（

0.05）.

Conclusion

DEX can reduce lipid accumulation in the liver，which may be related to the activation of α

-adrenoceptors and the MAPK/NF-κB signaling pathway.

关键词

Keywords

references

Younossi Z ， Tacke F ， Arrese M ， et al . Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [J ] . Hepatology ， 2019 ， 69 （ 6 ）： 2672 - 2682 ．

Zhang X ， Fan LN ， Wu JF ， et al . Macrophage p38α promotes nutritional steatohepatitis through M1 polarization [J ] . J Hepatol ， 2019 ， 71 （ 1 ）： 163 - 174 ．

Marjot T ， Moolla A ， Cobbold JF ， et al . Nonalcoholic fatty liver disease in adults：current concepts in etiology，outcomes，and management [J ] . Endocr Rev ， 2020 ， 41 （ 1 ）： bnz009 ．

Jennison E ， Patel J ， Scorletti E ， et al . Diagnosis and management of non-alcoholic fatty liver disease [J ] . Postgrad Med J ， 2019 ， 95 （ 1124 ）： 314 - 322 ．

Ross AP ， Darling JN ， Parent MB . Excess intake of fat and sugar potentiates epinephrine-induced hyperglycemia in male rats [J ] . J Diabetes Complications ， 2015 ， 29 （ 3 ）： 329 - 337 ．

Polyzos SA ， Kountouras J ， Zavos C . Nonalcoholic fatty liver disease：the pathogenetic roles of insulin resistance and adipocytokines [J ] . Curr Mol Med ， 2009 ， 9 （ 3 ）： 299 - 314 ．

Donnelly KL ， Smith CI ， Schwarzenberg SJ ， et al . Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease [J ] . J Clin Invest ， 2005 ， 115 （ 5 ）： 1343 - 1351 ．

Liu FF ， Zhu SJ ， Ni LF ， et al . Dexmedetomidine alleviates insulin resistance in hepatocytes by reducing endoplasmic reticulum stress [J ] . Endocrine ， 2020 ， 67 （ 1 ）： 87 - 94 ．

Coursin DB ， Coursin DB ， Maccioli GA . Dexmedetomidine [J ] . Curr Opin Crit Care ， 2001 ， 7 （ 4 ）： 221 - 226 ．

Maagaard M ， Barbateskovic M ， Perner A ， et al . Dexmedetomidine for the management of delirium in critically ill patients-a protocol for a systematic review [J ] . Acta Anaesthesiol Scand ， 2019 ， 63 （ 4 ）： 549 - 557 ．

Skrobik Y ， Duprey MS ， Hill NS ， et al . Low-dose nocturnal dexmedetomidine prevents ICU delirium. A randomized，placebo-controlled trial [J ] . Am J Respir Crit Care Med ， 2018 ， 197 （ 9 ）： 1147 - 1156 ．

Zhang Y ， Ran K ， Zhang SB ， et al . Dexmedetomidine may upregulate the expression of caveolin‑1 in lung tissues of rats with sepsis and improve the short‑term outcome [J ] . Mol Med Rep ， 2017 ， 15 （ 2 ）： 635 - 642 ．

马立刚，王哲银 . 新型独特的α2受体激动药：右美托咪定 [J ] . 中国基层医药， 2012 ， 19 （ 3 ）： 446 - 448 ．

Ma LG ， Wang ZG . A novel and unique α2 receptor agonist: dexmedetomidine [J ] . Chinese Journal of Primary Medicine , 2012 , 19 ( 3 ): 446 - 448 .

刘　娜，张晓岚，梁传栋，等 . 肝纤维化过程中去甲肾上腺素各受体亚型表达的动态变化 [J ] . 中华肝脏病杂志， 2009 ， 17 （ 9 ）： 653 - 656 ．

Liu N ， Zhang XL ， Liang CD ， et al . Dynamic changes of α-AR，β1-AR and β2-AR expression during hepatic fibrogenesis [J ] . Chin J Hepatol ， 2009 ， 17 （ 9 ）： 653 - 656 ．

Tao LF ， Guo XL ， Xu M ， et al . Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice [J ] . Pharmacol Res Perspect ， 2021 ， 9 （ 1 ）： e00700 ．

Guo YJ ， Yu JJ ， Wang CX ， et al . miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1 [J ] . J Mol Endocrinol ， 2017 ， 59 （ 3 ）： 205 - 217 ．

Zhang X ， Shen JY ， Man K ， et al . CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis [J ] . J Hepatol ， 2014 ， 61 （ 6 ）： 1365 - 1375 ．

郭福春，王力强，张　静，等 . 二甲双胍联合MCT1抑制剂α-氰基-4-羟基苯乙烯治疗小鼠Lewis肺癌的研究 [J ] . 四川大学学报（医学版）， 2013 ， 44 （ 3 ）： 375 - 378 ．

Guo FC ， Wang LQ ， Zhang J ， et al . Study on the anti-lewis lung carcinoma effect of metformin combined with MCT1 inhibitor CHC [J ] . J Sichuan Univ（Med Sci）， 2013 ， 44 （ 3 ）： 375 - 378

Frederico MJ ， Vitto MF ， Cesconetto PA ， et al . Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice [J ] . Scand J Gastroenterol ， 2011 ， 46 （ 11 ）： 1381 - 1388 ．

Wu JS ， Kao MH ， Tsai HD ， et al . Clinacanthus nutans mitigates neuronal apoptosis and ischemic brain damage through augmenting the C/EBPβ-driven PPAR-γ transcription [J ] . Mol Neurobiol ， 2018 ， 55 （ 7 ）： 5425 - 5438 ．

Bulow NMH ， Colpo E ， Duarte MF ， et al . Inflammatory response in patients under coronary artery bypass grafting surgery and clinical implications：a review of the relevance of dexmedetomidine use [J ] . ISRN Anesthesiol ， 2014 ， 2014 ： 1 - 28 ．

Liao ZX ， Cao DX ， Han X ， et al . Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats [J ] . Brain Res Bull ， 2014 ， 107 ： 69 - 78 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of intravenous dexmedetomidine on median effective concentration of ropivacaine for caudal block

Related Author

Wang Fu

Zhang Liang

Liu Mengxiao

Pang Qianyun

Shen Qian

Qi Yi

Xiong Zhangrong

Feng Bin

Related Institution

Department of Anesthesiology，Chongqing Traditional Chinese Medicine Hospital

Department of Anesthesiology,Chongqing University Cancer Hospital & Chongqing Cancer Institute &Chongqing Cancer Hospital

Department of Respiratory,Nanshan District People’s Hospital

Department of Anesthesiology,Children’s Hospital of Chongqing Medical University

⁰